Language across the Lifespan in Fragile X Syndrome: Characteristics and Considerations for Assessment.
Fragile X syndrome
intellectual disability
language assessment
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
04 Apr 2020
04 Apr 2020
Historique:
received:
03
03
2020
revised:
27
03
2020
accepted:
30
03
2020
entrez:
9
4
2020
pubmed:
9
4
2020
medline:
9
4
2020
Statut:
epublish
Résumé
While it is widely acknowledged that language development is delayed for the majority of individuals with fragile X syndrome (FXS), there has been limited research into how best to assess this area. This study aimed to deepen the understanding of standardized language assessment in FXS by addressing the three following objectives: (1) Examine the feasibility and validity of widely-used, standardized assessments in participants with FXS; (2) describe linguistic and cognitive profiles for a large sample of individuals with FXS; and (3) Compare results obtained from objective testing in clinic to those obtained using caregiver report. Results indicate that previous results indicating strong correlations between cognition and language results hold true across a wide range of ages as well as across multiple assessments, with an exception in very young children. Caregiver report tended to give lower estimates of language ability than what was found using an objectively administered assessment. Appropriate assessments remain difficult to find as a significant percentage of individuals scored at floor when scaled scores were calculated. Further, a sub-group of participants were coded for behavioral response to testing demands, the majority being able to complete a standardized assessment. These results speak to the need for assessments that provide a wider range of items so individuals can both achieve a valid score and demonstrate progress in their attainment of language skills.
Identifiants
pubmed: 32260354
pii: brainsci10040212
doi: 10.3390/brainsci10040212
pmc: PMC7226519
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCBDD CDC HHS
ID : U01 DD001185
Pays : United States
Organisme : CDC HHS
ID : 1 U01 DD001186-01
Pays : United States
Références
Am J Speech Lang Pathol. 2006 Aug;15(3):247-54
pubmed: 16896174
Am J Med Genet. 1991 Feb-Mar;38(2-3):493-7
pubmed: 2018092
Am J Speech Lang Pathol. 2006 Nov;15(4):353-64
pubmed: 17102146
J Autism Dev Disord. 1997 Jun;27(3):233-43
pubmed: 9229256
J Autism Dev Disord. 2008 Oct;38(9):1751-7
pubmed: 18369716
Am J Hum Genet. 2009 Oct;85(4):503-14
pubmed: 19804849
J Autism Dev Disord. 2019 Jul 24;:
pubmed: 31342442
Am J Ment Retard. 2001 May;106(3):216-30
pubmed: 11389664
Am J Speech Lang Pathol. 2013 Nov;22(4):615-26
pubmed: 23813199
J Neurodev Disord. 2014;6(1):16
pubmed: 26491488
J Autism Dev Disord. 1987 Dec;17(4):457-68
pubmed: 3479423
J Neurodev Disord. 2019 Oct 16;11(1):25
pubmed: 31619160
J Dev Behav Pediatr. 2013 Sep;34(7):508-22
pubmed: 24042082
Pediatrics. 2009 Jan;123(1):378-90
pubmed: 19117905
Am J Ment Retard. 2003 May;108(3):149-60
pubmed: 12691594
Autism Res. 2013 Dec;6(6):479-93
pubmed: 24353165
Int J Lang Commun Disord. 2011 Mar-Apr;46(2):216-30
pubmed: 21401819
J Child Adolesc Psychopharmacol. 2006 Oct;16(5):525-40
pubmed: 17069542
Am J Ment Retard. 2007 May;112(3):177-93
pubmed: 17542655
J Speech Lang Hear Res. 2017 Feb 1;60(2):422-434
pubmed: 28219082
J Dev Behav Pediatr. 2013 May;34(4):245-51
pubmed: 23669871
J Cogn Neurosci. 2005 Apr;17(4):591-604
pubmed: 15829080
J Intellect Disabil Res. 2007 Apr;51(Pt 4):318-26
pubmed: 17326813
Contemp Sch Psychol. 2018 Dec;22(4):443-457
pubmed: 30420939
J Ment Defic Res. 1986 Jun;30 ( Pt 2):129-48
pubmed: 3735410